General Information of the Compound
Compound ID
CP0408926
Compound Name
US10022352, Compound 315
    Show/Hide
Synonyms
VX-661
    Show/Hide
Structure
Formula
C26H27F3N2O6
Molecular Weight
520.504
Canonical SMILES
CC(C)(CO)c1cc2cc(NC(=O)C3(CC3)c3ccc4OC(F)(F)Oc4c3)c(F)cc2n1C[C@@H](O)CO
    Show/Hide
InChI
InChI=1S/C26H27F3N2O6/c1-24(2,13-33)22-8-14-7-18(17(27)10-19(14)31(22)11-16(34)12-32)30-23(35)25(5-6-25)15-3-4-20-21(9-15)37-26(28,29)36-20/h3-4,7-10,16,32-34H,5-6,11-13H2,1-2H3,(H,30,35)/t16-/m1/s1
    Show/Hide
InChIKey
MJUVRTYWUMPBTR-MRXNPFEDSA-N
CAS
1152311-62-0
Physicochemical Property
logP
3.3953
Rotatable Bonds
8
Heavy Atom Count
37
Polar Areas
113.18
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
7
Complexity
37

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 46199646
SID: 96053596
ChEMBL ID
CHEMBL3544914
DrugBank ID
DB11712
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000035 NIH 3T3 Mus musculus (Mouse)  1
1
EC50 = 272 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( VX-661 )
Drug Name VX-661
Company Vertex Pharmaceuticals Inc
Indication
Cystic fibrosis
Phase 2
Target(s)
cAMP-dependent chloride channel (CFTR)
Regulator